Announcements | PAGEPress srl

News & Announcements

COVID-19 lockdown: impact on online gambling, online shopping, web navigation and online pornography

2021-02-15

The COVID-19 pandemic and control measures may have had an impact on unpleasant emotions experimented during the lockdown (LD). This may have increased the number of hours spent online and could have impacted the quality of the enacted behavior, in terms of loss of control of Internet use. In this online survey, we were interested in measure how much loss of control was perceived regarding online gambling, online shopping, the fruition of online pornographic content and web navigation. [https://doi.org/10.4081/jphr.2021.1959]

Read more about COVID-19 lockdown: impact on online gambling, online shopping, web navigation and online pornography
SARS-CoV-2 related pneumonia in an adult with cystic fibrosis: natural favourable clinical course or effective therapy?

2021-01-25

We report the case of a man affected by cystic fibrosis who developed a severe SARS-CoV-2 related pneumonia in March 2020. In addition to lopinavir/ritonavir and hydroxychloroquine, he was treated with two doses of tocilizumab, displaying a significant clinical improvement. This is the first case described in the literature of an adult patient affected by cystic fibrosis who received tocilizumab for COVID-19, with documented total recovery, also assessed by a spirometry.

Read more about SARS-CoV-2 related pneumonia in an adult with cystic fibrosis: natural favourable clinical course or effective therapy?
COVID-19: general overview, pharmacological options and ventilatory support strategies

2020-12-14

The novel coronavirus called “Severe Acute Respiratory Syndrome Coronavirus 2” (SARS-CoV-2) caused an outbreak in December 2019, starting from the Chinese city of Wuhan, in the Hubei province, and rapidly spreading to the rest of the world. Consequently, the World Health Organization (WHO) declared that the coronavirus disease of 2019 (COVID-19) can be characterized as a pandemic. During COVID-19 several immunological alterations have been observed: in plasma of severe patients, inflammatory cytokines are at a much higher concentration (“cytokine storm”). These aspects are associated with pulmonary inflammation and parenchymal infiltrates with an extensive lung tissue damage in COVID-19 patients.

https://mrmjournal.org/mrm/article/view/708

Read more about COVID-19: general overview, pharmacological options and ventilatory support strategies
Hydroxychloroquine and QTc: beyond COVID-19

2020-11-24

Hydroxychloroquine is an antimalarial drug also known for its anti-inflammatory and antiviral effects, which have raised the interest of many researchers for its potential use in COVID-19 patients.
Read more about Hydroxychloroquine and QTc: beyond COVID-19
Prevention and safety in the dental office after Novel Human Coronavirus outbreak: unresolved questions and future directions

2020-10-26

Since the outbreak of the Novel Human Coronavirus epidemic, researchers around the world focused their efforts on tackling this global emergency. Research labs are joining forces to find a therapy and a preventive vaccine. Preventive and extraordinary safety measures are crucial to reduce the spread of SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) among Health-Care Professionals (HCP). [continue]

Read more about Prevention and safety in the dental office after Novel Human Coronavirus outbreak: unresolved questions and future directions
Guidance to postmortem collection and storage of biological specimens for the diagnosis of Covid19 infection

2020-09-07

The following document is based on the current knowledge of SARS-CoV-2 and the related disease (COVID-19). The Italian Institute of Health (ISS) is monitoring the virus spread throughout the country through daily reports sent by individual regions and regional reference laboratories.

Read more about Guidance to postmortem collection and storage of biological specimens for the diagnosis of Covid19 infection
SARS-CoV-2 pandemic in Italy: ethical and organizational considerations

2020-08-11

The current SARS-CoV-2 pandemic is still raging in Italy. The country is currently plagued by a huge burden of virus relatedcases and deaths. So far, the disease has highlighted a number of problems, some in common with other Countries and others peculiar to Italy which has suffered from a mortality rate higher than that observed in China and in most Countries in the world.

Multidisciplinary Respiratory Medicine - https://doi.org/10.4081/mrm.2020.672
Read more about SARS-CoV-2 pandemic in Italy: ethical and organizational considerations
COVID-19 and cardiovascular disease in elderly patients: a challenge in the challenge

2020-07-07

On 11 March 2020, the World Health Organization declared a pandemic state, in relation to the spread of the severe acute respiratory syndrome-coronavirus disease- 2, responsible for the coronavirus disease- 2019 (COVID-19). The pandemical blast of COVID-19 uncovered well known weakness of financial chain and put our economic organizations facing off dramatic consequences if new strategies will not be developed to adapt health-care on detailed sub-groups of patients. READ MORE.

https://doi.org/10.4081/gc.2020.9121
Read more about COVID-19 and cardiovascular disease in elderly patients: a challenge in the challenge
The Journal of ADOI (Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanita' pubblica)

2020-06-11

Dermatology Reports is the official Journal of ADOI (Associazione Dermatologi-Venereologi Ospedalieri Italiani e della sanità pubblica) publishing scientific papers about skin diseases. Manuscripts dealing with research, biology, epidemiology, clinics of all skin-related diseases are welcome. Dermatology Reports publishes original articles, reviews, brief reports and case reports.

The 58th ADOI National Congress will be held in 29 September - 2nd October 2021.
Read more about The Journal of ADOI (Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanita' pubblica)
SARS-CoV-2, “common cold” coronaviruses’ cross-reactivity and “herd immunity”: The razor of Ockham (1285-1347)?

2020-05-29

After the rapid spread of coronavirus-19 infectious disease (COVID-19) worldwide between February and April 2020, with a total of 5,267,419 confirmed cases and 341,155 deaths as of May 25, 2020, in the last weeks we are observing a decrease in new infections in European countries, and the confirmed cases are not as severe as in the past, so much so that the number of patients transferred to intensive care for the worsening of the systemic and pulmonary disease is dramatically decreasing [...]

Infectious Disease Reports https://doi.org/10.4081/idr.2020.8647
Nicola Petrosillo, National Institute for Infectious Diseases “L. Spallanzani”, IRCCS, Rome, Italy.
Read more about SARS-CoV-2, “common cold” coronaviruses’ cross-reactivity and “herd immunity”: The razor of Ockham (1285-1347)?
How the COVID-19 infection tsunami revolutionized the work of respiratory physiotherapists: an experience from Northern Italy

2020-05-20

Due to COVID-19 outbreak, to lighten the burden of acute and critical care hospitals, some respiratory rehabilitation departments have been used to host patients with COVID-19 in the post-acute phase. This new and unexpected situation required a change of roles and scheduling of the rehabilitation teams. In this manuscript we describe the unexpected and urgent organizational change of the Cardio-Pulmonary Rehabilitation (CPR) service during the COVID-19 emergency in a Northern Italian rehabilitation hospital, focusing on the Respiratory Physiotherapists’ (RPTs) role.

Monaldi Archives for Chest Disease https://doi.org/10.4081/monaldi.2020.1085
Read more about How the COVID-19 infection tsunami revolutionized the work of respiratory physiotherapists: an experience from Northern Italy
Ambroxol for the treatment of children with acute and chronic respiratory diseases: an overview of efficacy and safety

2020-05-19

Ambroxol (2-amino-3,5-dibromo-N-[trans-4-hydroxycyclohexyl]benzylamine), an over-thecounter product, is a mucoactive agent and has been used widely to treat both acute and chronic respiratory diseases since 1978. This review aims to provide an overview of the clinical evidence available on the use of ambroxol in children with acute and chronic respiratory diseases. Data for this review were obtained from both published and unpublished clinical studies, and real-world evidence studies. Although conducted prior to the introduction of Good Clinical Practice (GCP), these studies, representing almost 1,300 pediatric patients, report strong clinical outcomes following the use of ambroxol in pediatric patients. Furthermore, ....

Multidisciplinary Respiratory Medicine https://doi.org/10.4081/mrm.2020.511
Read more about Ambroxol for the treatment of children with acute and chronic respiratory diseases: an overview of efficacy and safety
COVID-19 and clinical mimics. Correct diagnosis is the key to appropriate therapy

2020-05-07

#COVIDー19 and clinical mimics. Challenges faced while approaching any case of shortness of breath, or other common upper respiratory symptoms during the current #COVID19 #pandemic era.

Monaldi Archives of Chest Disease https://doi.org/10.4081/monaldi.2020.1327

As of 29 April 2020, across the globe, there are 3,216,353 confirmed Coronavirus disease 2019 (COVID-19 disease) with 227,894 deaths. The health care infrastructure of most of the countries is overwhelmed due to the gigantic upsurge of the new cases within a short time period. Most of the beds in the regular wards and critical care units are currently occupied by either people under investigation (PUI) or COVID-19 confirmed cases. We hereby discuss the challenges faced while approaching any case of shortness of breath, or other common upper respiratory symptoms during the current COVID-19 pandemic era.
Read more about COVID-19 and clinical mimics. Correct diagnosis is the key to appropriate therapy
Oxygen-ozone immunoceutical therapy in COVID-19 outbreak: facts and figures

2020-04-10

The problems related to the approach to the outbreak of COVID-19 in the world require that all possible effective treatment options be explored. The clinical criterion of the researcher is not to refuse a priori, but to verify and evaluate the proposals that are made. Italian Society of Oxygen Ozone Therapy (SIOOT) proposed to the Italian ISS (Italian Institute of Health) to use oxygen ozone therapy (O2O3) in patients with COVID-19. (...)

https://doi.org/10.4081/ozone.2020.9014
Read more about Oxygen-ozone immunoceutical therapy in COVID-19 outbreak: facts and figures
Respiratory physiotherapy in patients with COVID-19 infection in acute setting: a Position Paper of the Italian Association of Respiratory Physiotherapists (ARIR)

2020-04-10

On February 2020, Italy, especially the northern regions, was hit by an epidemic of the new SARS-Cov-2 coronavirus that spread from China between December 2019 and January 2020.

https://doi.org/10.4081/monaldi.2020.1285
Read more about Respiratory physiotherapy in patients with COVID-19 infection in acute setting: a Position Paper of the Italian Association of Respiratory Physiotherapists (ARIR)
Recommendations for COVID-19 Clinical Management

2020-03-17

Recommendations for COVID-19 Clinical Management from the National Institute for the Infectious Diseases “L. Spallanzani”, IRCCS, Rome, Italy.
Read more about Recommendations for COVID-19 Clinical Management
Launching Ricerca Psicoanalitica

2020-01-24

Ricerca Psicoanalitica is a member of the Council of Editors of Psychoanalytic Journals and has been for over two decades the journal of relations in psychoanalysis in Italy.
Read more about Launching Ricerca Psicoanalitica
Launching Multidisciplinary Respiratory Medicine

2020-01-24

Multidisciplinary Respiratory Medicine is the official journal of the Italian Respiratory Society - Società Italiana di Pneumologia (IRS/SIP).
Read more about Launching Multidisciplinary Respiratory Medicine
PAGEPress Publications signs Declaration on Research Assessment (DORA)

2019-11-11

PAGEPress has signed the San Francisco Declaration on Research Assessment (DORA).
DORA is a worldwide initiative covering all scholarly disciplines which recognizes the need to improve the ways in which the outputs of scholarly research are evaluated and seeks to develop and promote best practice. To date it has been signed by over 1500 organizations and around 15000 individuals.
Read more about PAGEPress Publications signs Declaration on Research Assessment (DORA)
Launching Infectious Diseases and Herbal Medicine

2019-09-04

Infectious Diseases and Herbal Medicine (IDHM) is an international, Open Access, peer-reviewed, authoritative journal providing basic and applied research.
Read more about Launching Infectious Diseases and Herbal Medicine
Launching Beyond Rheumatology

2019-09-04

Beyond Rheumatology is an international, open access, peer-reviewed journal of CReI (Collegio dei Reumatologi Italiani), committed to publishing new discoveries on diagnostic, prognostic, clinical and therapeutic topics about rheumatism and allied conditions.
Read more about Launching Beyond Rheumatology
Giornale Italiano di Endodonzia: a new life begins!

2019-09-03

The Giornale Italiano di Endodonzia was founded in 1987 and is the official journal of the Italian Society of Endodontics (SIE). It is a peer-reviewed journal publishing original articles on clinical research and/or clinical methodology, case reports related to Endodontics. The Journal evaluates also contributes in restorative dentistry, dental traumatology, experimental pathophysiology, pharmacology and microbiology dealing with Endodontics. The Giornale Italiano di Endodonzia is indexed in Scopus, Science Direct, SCImago, Embase, Google Scholar, Academic Search EBSCO, OCLC.
Read more about Giornale Italiano di Endodonzia: a new life begins!